|
1
|
Brenner SA, Zacheja S, Schäffer M,
Feilhauer K, Bischoff SC and Lorentz A: Soluble CD14 is essential
for lipopolysaccharide-dependent activation of human intestinal
mast cells from macroscopically normal as well as Crohn's disease
tissue. Immunology. 143:174–183. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gan X, Liu D, Huang P, Gao W, Chen X and
Hei Z: Mast-cell-releasing tryptase triggers acute lung injury
induced by small intestinal ischemia-reperfusion by activating
PAR-2 in rats. Inflammation. 35:1144–1153. 2012. View Article : Google Scholar
|
|
3
|
Gan X, Su G, Zhao W, Huang P, Luo G and
Hei Z: The mechanism of sevoflurane preconditioning-induced
protections against small intestinal ischemia reperfusion injury is
independent of mast cell in rats. Mediators Inflamm.
2013:3787032013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hamilton MJ, Sinnamon MJ, Lyng GD,
Glickman JN, Wang X, Xing W, Krilis SA, Blumberg RS, Adachi R, Lee
DM and Stevens RL: Essential role for mast cell tryptase in acute
experimental colitis. Proc of the Natl Acad Sci USA. 108:290–295.
2011. View Article : Google Scholar
|
|
5
|
Zhao W, Zhou S, Yao W, Gan X, Su G, Yuan D
and Hei Z: Propofol prevents lung injury after intestinal
ischemia-reperfusion by inhibiting the interaction between mast
cell activation and oxidative stress. Life Sci. 108:80–87. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao P, Metcalf M and Bunnett NW: Biased
signaling of protease-activated receptors. Front Endocrinol
(Lausanne). 5:672014.
|
|
7
|
Rothmeier AS and Ruf W: Protease-activated
receptor 2 signaling in inflammation. Semin Immunopathol.
34:133–149. 2012. View Article : Google Scholar
|
|
8
|
Yoshida N, Takagi T, Isozaki Y, Suzuki T,
Ichikawa H and Yoshikawa T: Proinflammatory role of
protease-activated receptor-2 in intestinal ischemia/reperfusion
injury in rats. Mol Med Rep. 4:81–86. 2011.PubMed/NCBI
|
|
9
|
Kang DS, Tian X and Benovic JL: Role of
β-arrestins and arrestin domain-containing proteins in G
protein-coupled receptor trafficking. Curr Opin Cell Biol.
27:63–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zoudilova M, Min J, Richards HL, Carter D,
Huang T and DeFea KA: beta-Arrestins scaffold cofilin with
chronophin to direct localized actin filament severing and membrane
protrusions downstream of protease-activated receptor-2. J Biol
Chem. 285:14318–14329. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jacob C, Yang PC, Darmoul D, Amadesi S,
Saito T, Cottrell GS, Coelho AM, Singh P, Grady EF, Perdue M and
Bunnett NW: Mast cell tryptase controls paracellular permeability
of the intestine. Role of protease-activated receptor 2 and
beta-arrestins. J Biol Chem. 280:31936–31948. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ge L, Shenoy SK, Lefkowitz RJ and DeFea K:
Constitutive protease-activated receptor-2-mediated migration of
MDA MB-231 breast cancer cells requires both beta-arrestin-1 and
-2. J Biol Chem. 279:55419–55424. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fan H, Bitto A, Zingarelli B, Luttrell LM,
Borg K, Halushka PV and Cook JA: Beta-arrestin 2 negatively
regulates sepsis-induced inflammation. Immunology. 130:344–351.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ho J, Du Y, Wong OG, Siu MK, Chan KK and
Cheung AN: Downregulation of the gli transcription factors
regulator kif7 facilitates cell survival and migration of
choriocarcinoma cells. PLoS One. 9:e1082482014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Du RW, Du RH and Bu WG: β-Arrestin 2
mediates the anti-inflammatory effects of fluoxetine in
lipopolysaccharide-stimulated microglial cells. J Neuroimmune
Pharmacol. 9:582–590. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lakshmikanthan V, Zou L, Kim JI, Michal A,
Nie Z, Messias NC, Benovic JL and Daaka Y: Identification of
betaArrestin2 as a corepressor of androgen receptor signaling in
prostate cancer. Proc Natl Acad Sci USA. 106:9379–9384. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu D, Gan X, Huang P, Chen X, Ge M and
Hei Z: Inhibiting tryptase after ischemia limits small intestinal
ischemia-reperfusion injury through protease-activated receptor 2
in rats. J Trauma Acute Care Surg. 73:1138–1144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang ZY, Wang P and Bjorling DE: Role of
mast cells and protease-activated receptor-2 in cyclooxygenase-2
expression in urothelial cells. Am J Physiol Regul Integr Comp
Physiol. 297:R1127–R1135. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pejler G, Rönnberg E, Waern I and
Wernersson S: Mast cell proteases: Multifaceted regulators of
inflammatory disease. Blood. 115:4981–4990. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cui Y, Dahlin JS, Feinstein R, Bankova LG,
Xing W, Shin K, Gurish MF and Hallgren J: Mouse mast cell
protease-6 and MHC are involved in the development of experimental
asthma. J Immunol. 193:4783–4789. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eliakim R, Karmeli F, Okon E and
Rachmilewitz D: Ketotifen effectively prevents mucosal damage in
experimental colitis. Gut. 33:1498–1503. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hagel AF, deRossi T, Zopf Y, Konturek P,
Dauth W, Kressel J, Hahn EG and Raithel M: Mast cell tryptase
levels in gut mucosa in patients with gastrointestinal symptoms
caused by food allergy. Int Arch Allergy Immunol. 160:350–355.
2013. View Article : Google Scholar
|
|
23
|
Tsujii K, Andoh T, Ui H, Lee JB and
Kuraishi Y: Involvement of tryptase and proteinase-activated
receptor-2 in spontaneous itch-associated response in mice with
atopy-like dermatitis. J Pharmacol Sci. 109:388–395. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ebeling C, Forsythe P, Ng J, Gordon JR,
Hollenberg M and Vliagoftis H: Proteinase-activated receptor 2
activation in the airways enhances antigen-mediated airway
inflammation and airway hyperresponsiveness through different
pathways. J Allergy Clin Immunol. 115:623–630. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Groschwitz KR, Wu D, Osterfeld H, Ahrens R
and Hogan SP: Chymase-mediated intestinal epithelial permeability
is regulated by a protease-activating receptor/matrix
metalloproteinase-2-dependent mechanism. Am J Physiol Gastrointest
Liver Physiol. 304:G479–G489. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zoudilova M, Kumar P, Ge L, Wang P, Bokoch
GM and DeFea KA: Beta-arrestin-dependent regulation of the cofilin
pathway downstream of protease-activated receptor-2. J Biol Chem.
282:20634–20646. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nichols HL, Saffeddine M, Theriot BS,
Hedge A, Polley D, El-Mays T, Vliagoftis H, Hollenberg MD, Wilson
EH, Walker JK and DeFea KA: β-Arrestin-2 mediates the
proinflammatory effects of proteinase-activated receptor-2 in the
airway. Proc Natl Acad Sci USA. 109:16660–16665. 2012. View Article : Google Scholar
|
|
28
|
Darling NJ and Cook SJ: The role of MAPK
signalling pathways in the response to endoplasmic reticulum
stress. Biochim Biophys Acta. 1843:2150–2163. 2014. View Article : Google Scholar : PubMed/NCBI
|
